Trial Identifier: | D0817R00010 |
Sponsor: | AstraZeneca |
NCTID:: | NCT04553926 |
Start Date: | February 2021 |
Primary Completion Date: | June 2025 |
Study Completion Date: | June 2025 |
Condition: | Breast Cancer; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
South Korea | Busan, South Korea, 49267 |
South Korea | Busan, South Korea, 48108 |
South Korea | Busan, South Korea, 50615 |
South Korea | Busan, South Korea, 47392 |
South Korea | Cheongju, South Korea, 28644 |
South Korea | Daegu, South Korea, 42415 |
South Korea | Daejeon, South Korea, 35365 |
South Korea | Goyang, South Korea, 10408 |
South Korea | Incheon, South Korea, 21565 |
South Korea | Seongnam, South Korea, 13620 |
South Korea | Seoul, South Korea, 06273 |
South Korea | Seoul, South Korea, 05030 |
South Korea | Seoul, South Korea, 04401 |
South Korea | Seoul, South Korea, ,02841 |
South Korea | Seoul, South Korea, 14577 |
South Korea | Seoul, South Korea, 03722 |
South Korea | Seoul, South Korea, 04763 |
South Korea | Seoul, South Korea, 04763 |
South Korea | Seoul, South Korea, 04763 |
South Korea | Seoul, South Korea, 04763 |
South Korea | Seoul, South Korea, 04763 |
South Korea | Seoul, South Korea, 04763 |
South Korea | Uijeongbu, South Korea, 11765 |
South Korea | Yangsan, South Korea, 50612 |